Tuesday, July 30, 2019

Warning letter woes: Dr Reddy#39;s expects FDA inspection of Andhra Pradesh plant by year end

Warning letter woes: Dr Reddy#39;s expects FDA inspection of Andhra Pradesh plant by year end "On the regulatory front, the API plant at Miryalaguda was given an Establishment Inspection Report (EIR) in 2017 resolving the earlier warning letter. We also received EIR for the injectable site at the Duvvada and we are awaiting for CTO VI site at Srikakulam.

from Moneycontrol Business News https://ift.tt/2Mrpt5k
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US stock: S&P 500 ends lower as investors weigh data, Middle East tensions

The S&P 500's streak came to an end, falling from its peak as weaker retail sales suggested caution among consumers. Despite a stron...